Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 2—February 2009

Dispatch

Mycobacterium bolletii Respiratory Infections

Toïdi Adékambi1 and Michel DrancourtComments to Author 
Author affiliations: Université de la Méditerranée, Marseille, France

Main Article

Table

Antimicrobial drug susceptibility test results (MICs) for Mycobacterium bolletii isolates*

Antimicrobial agent Patient 1 Patient 2 Patient 3 Patient 4
Penicillin >32 >32 >32 >32
Amoxicillin >256 >256 >256 >256
Amoxicillin clavulanate (disc 20 µg + 10 µg) >4 >4 >4 >4
Cefoxitin >256 >256 >256 >256
Ceftriaxone >256 >256 >256 >256
Cefotaxime >256 >256 >256 >256
Imipenen >32 >32 >32 >32
Doxycycline >32 >32 >32 >32
Minocycline >256 >256 >256 >256
Clarithromycin >256 >256 >256 >256
Erythromycin >256 >256 >256 >256
Azithromycin >256 >256 >256 >256
Amikacin 32 48 32 48
Tobramycin >32 >32 >32 >32
Ciprofloxacin >32 >32 >32 >32
Ofloxacin >32 >32 >32 >32
Sparfloxacin >32 >32 >32 >32
Rifampicin >32 >32 >32 >32
Metronidazole >256 >256 >256 >256
Teicoplanine >256 >256 >256 >256
Vancomycin >256 >256 >256 >256
Trimethoprim-sulfamethoxazole >32 >32 >32 >32

*Values given in μg/mL.

Main Article

1Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

TOP